Postoperative hyperphosphatemia significantly associates with adverse survival in colorectal cancer patients

Authors

Zhong Ye, Division of Population Science, Department of Medical Oncology, Kimmel Cancer Center, Thomas Jefferson UniversityFollow
Juan P. Palazzo, Department of Pathology, Thomas Jefferson UniversityFollow
Liz Lin, Division of Population Science, Department of Medical Oncology, Kimmel Cancer Center, Thomas Jefferson University
Yinzhi Lai, Division of Population Science, Department of Medical Oncology, Kimmel Cancer Center, Thomas Jefferson UniversityFollow
Fran Guiles, Oncology Data Service, Thomas Jefferson UniversityFollow
Ronald E. Myers, PhD, DSW, Director, Division of Population Science, and Professor, Department of Medical Oncology, Jefferson Medical CollegeFollow
Jin Han, Department of Pharmacy, Rush University Medical Center
Jinliang Xing, Experimental Teaching Center, Fourth Military Medical UniversityFollow
Hushan Yang, Division of Population Science, Department of Medical Oncology, Kimmel Cancer Center, Thomas Jefferson UniversityFollow

Document Type

Article

Publication Date

2013

Comments

This article has been peer reviewed. It was published in: Journal of Gastroenterology and Hepatology (Australia).

Volume 28, Issue 9, September 2013, Pages 1469-1475.

The published version is available at DOI: 10.1111/jgh.12237

Copyright © 2013 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd.

Recommended Citation

Ye, Zhong; Palazzo, Juan P.; Lin, Liz; Lai, Yinzhi; Guiles, Fran; Myers, PhD, DSW, Ronald E.; Han, Jin; Xing, Jinliang; and Yang, Hushan, "Postoperative hyperphosphatemia significantly associates with adverse survival in colorectal cancer patients" (2013). Department of Medical Oncology Faculty Papers. Paper 47.
https://jdc.jefferson.edu/medoncfp/47